A PRELIMINARY REPORT ON A NEW ANTITUBERCULOUS DRUG 4-AMINO-2-HYDROXY-PHENYL-1, 3, 4,-OXADIAZOL-2-OL WS 127.
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D035843:Biomedical Research; D001769:Blood; D003523:Cycloserine; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D005000:Ethionamide; D007538:Isoniazid; D051379:Mice; D010069:Oxadiazoles; D010600:Pharmacology; D011030:Pneumothorax; D011031:Pneumothorax, Artificial; D011718:Pyrazinamide; D013902:Radiography, Thoracic; D013183:Sputum; D013307:Streptomycin; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary; D014556:Urine
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D010069:Oxadiazoles; D011718:Pyrazinamide; D010131:Aminosalicylic Acid; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
AMINOSALICYLIC ACID; ANTITUBERCULAR AGENTS; BLOOD; CLINICAL RESEARCH; CYCLOSERINE; DRUG RESISTANCE, MICROBIAL; ETHIONIAMIDE; ISONIAZID; MICE; OXADIAZOLES; PHARMACOLOGY; PNEUMOTHORAX, ARTIFICIAL; PYRAZINAMIDE; SPUTUM; STREPTOMYCIN; THORACIC RADIOGRAPHY; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY; URINE